Holding(s) in Company

Huveaux PLC
09 February 2007


TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES


1. Identity of the issuer or the underlying issuer of existing shares to which
voting rights are attached (ii):

Huveaux PLC


2. Reason for the notification (please place an X inside the appropriate bracket
/s):


An acquisition or disposal of voting rights: ( X  )


An acquisition or disposal of financial instruments which may result in the
acquisition of shares already issued to which voting rights are attached: (    )


An event changing the breakdown of voting rights: (    )


Other (please specify) : (    )


3. Full name of person(s) subject to the notification obligation (iii):

AXA S.A, 25 Avenue Matignon, 75008 Paris and its group of companies.


4. Full name of shareholder(s) (if different from 3.) (iv):

.................


5. Date of the transaction (and date on which the threshold is crossed or
reached if different) (v):

07/02/2007


6. Date on which issuer notified:

08/02/2007


7. Threshold(s) that is/are crossed or reached:

     15%


8. Notified details:

.................


A: Voting rights attached to shares

Class/type of shares if Situation previous to the Triggering transaction (vi)
possible using the ISIN
CODE
                        Number of shares     Number of voting Rights (viii)
Ord 3112957                     31,667,790                          31,667,790

Resulting situation after the triggering transaction (vii)

Class/type of shares Number of    Number of voting rights    % of voting
if possible using    shares       (ix)                       rights
the ISIN CODE
                     Direct       Direct (x)   Indirect (xi) Direct   Indirect

Ord 3112957           8,913,045    8,913,045    22,954,745     5.86%     15.10%


B: Financial Instruments

Resulting situation after the triggering transaction (xii)

Type of      Expiration Exercise/      Number of voting rights that may % of
financial    Date       Conversion     be acquired if the instrument is voting
instrument   (xiii)     Period/ Date   exercised/ converted.            rights
                        (xiv)



Total (A+B)
Number of voting rights                      % of voting rights
                                
31,867,790                                   20.96%


9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable (xv):


AXA Framlington                        1,247,964   0.82%     (Non - Beneficial)
(Xerox Final Salary 
Pension Scheme)

AXA Framlington                          756,000   0.50%     (Non - Beneficial)
(Islington Group Pension Scheme)

AXA Framlington                        1,650,000   1.09%     (Non - Beneficial)
(SEI UK Equity)

AXA Framlington                        1,750,000   1.15%     (Non - Beneficial)
(Skandia UK global Best Ideas - GL)

AXA Framlington                       10,686,740   7.03%     (Non - Beneficial)
(Monthly Income)

AXA Framlington                        4,800,000   3.16%     (Non - Beneficial)
(UK Smaller Companies)

AXA Framlington                        1,085,479   0.71%     (Non - Beneficial)
(BAE Systems Pensions Fund CIF Trustees)

AXA Framlington                          475,647   0.31%     (Non - Beneficial)
(BAE Systems 2000 Pensions Fund)

Framlington onshore private clients      502,915   0.33%     (Non - Beneficial)

Please note that this notification includes a disclosure on behalf of the
following Investment Trust Companies which has/have a notifiable interest. The
interest of each Trust is listed below -


AXA Framlington

Throgmorton Trust                                       6,500,000
4.28 % (Beneficial)

Framlington Innovation Growth 2,413,045                1.59 % (Beneficial)


Proxy Voting:


10. Name of the proxy holder:

.................


11. Number of voting rights proxy holder will cease to hold:

.................


12. Date on which proxy holder will cease to hold voting rights:

.................


13. Additional information:

.................


14. Contact name:

Terry Marsh


15. Contact telephone number:

      020 7003 2637






                      This information is provided by RNS
            The company news service from the London Stock Exchange